Comorbidities of chronic obstructive pulmonary disease in Koreans: A population-based study

Journal of Korean Medical Science

Volumn 27, Issue 8, 2012, Pages 901-906

  Joo, Hyejin ^a   Park, Jinkyeong ^b   Lee, Sang Do ^a   Oh, Yeon Mok ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Chronic obstructive pulmonary disease; Comorbidity; Population based survey

Indexed keywords

ADULT; ARTICLE; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; RISK; RISK FACTOR; SOUTH KOREA; SPIROMETRY;

ADULT; COMORBIDITY; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REPUBLIC OF KOREA; RISK FACTORS; SPIROMETRY; THINNESS;

EID: 84866513067     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.8.901     Document Type: Article

References (20)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-76.
2. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797-9.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.
4. Yoo JW, Hong Y, Seo JB, Chae EJ, Ra SW, Lee JH, Kim EK, Baek S, Kim TH, Kim WJ, et al. Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation. J Korean Med Sci 2011; 26: 1606-12.
5. Hwang YI, Yoo KH, Sheen SS, Park JH, Kim SH, Yoon HI, Lim SC, Lee SY, Park JY, Park SJ. Prevalence of chronic obstructive pulmonary disease in Korea: the reasult of fourth Korean National Health and Nutrition Examination Survey. Tuberc Respir Dis 2011; 71: 328-34.
6. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50.
7. Tan WC, Ng TP. COPD in Asia: where East meets West. Chest 2008; 133: 517-27.
8. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-9.
9. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-5.
10. Izquierdo JL, Martinez A, Guzman E, de Lucas P, Rodriguez JM. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulmon Dis 2010; 5: 387-94.
11. Lu M, Yao WZ, Zhong NS, Zhou YM, Wang C, Chen P, Kang J, Huang SG, Chen BY, Wang CZ, et al. Asymptomatic patients of chronic obstructive pulmonary disease in China. Chin Med J (Engl) 2010; 123: 1494-9.
12. Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest 2011; 139: 165-73.
13. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-75.
14. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
15. Wells KB, Rogers W, Burnam MA, Camp P. Course of depression in patients with hypertension, myocardial infarction, or insulin-dependent diabetes. Am J Psychiatry 1993; 150: 632-8.
16. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15: 1090-6.
17. Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011; 12: 3.
18. Mukae H, Vincent R, Quinlan K, English D, Hards J, Hogg JC, Van Eeden SF. The effect of repeated exposure to particulate air pollution (PM10) on the bone marrow. Am J Respir Crit Care Med 2001; 163: 201-9.
19. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61: 23-8.
20. Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med 1989; 83: 195-8.